Skip to main content
Diagnostic Thoracic Pathology

Malignant Hematopoietic Disorders of the Mediastinum

Publication ,  Chapter
Pina-Oviedo, S
January 1, 2020

Hematopoietic tumors are among the most common neoplasms involving the mediastinum. Lymphomas alone represent ~60% of all mediastinal malignancies (Temes et al. Oncologist 5(3):179-84, 2000; Temes et al. West J Med 170(3):161-6, 1999). Mediastinal lymphoma includes cases of Hodgkin (~40%) and non-Hodgkin lymphoma (~60%) and few cases of acute myeloid leukemia/myeloid sarcoma. Hematolymphoid neoplasms confined to the mediastinum (primary disease) represent only 5% of cases, whereas mediastinal involvement in the setting of systemic disease occurs in 95% of cases (secondary involvement) (Macchiarini and Ostertag. Lancet Oncol 5(2):107-18, 2004; Strickler and Kurtin. Semin Diagn Pathol 8(1):2-13, 1991). This chapter is focused in the nodal mediastinal and thymic involvement by hematolymphoid neoplasms. Pleural and pulmonary hematolymphoid tumors are discussed in their respective chapters.

Duke Scholars

DOI

Publication Date

January 1, 2020

Start / End Page

1071 / 1119
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Pina-Oviedo, S. (2020). Malignant Hematopoietic Disorders of the Mediastinum. In Diagnostic Thoracic Pathology (pp. 1071–1119). https://doi.org/10.1007/978-3-030-36438-0_32
Pina-Oviedo, S. “Malignant Hematopoietic Disorders of the Mediastinum.” In Diagnostic Thoracic Pathology, 1071–1119, 2020. https://doi.org/10.1007/978-3-030-36438-0_32.
Pina-Oviedo S. Malignant Hematopoietic Disorders of the Mediastinum. In: Diagnostic Thoracic Pathology. 2020. p. 1071–119.
Pina-Oviedo, S. “Malignant Hematopoietic Disorders of the Mediastinum.” Diagnostic Thoracic Pathology, 2020, pp. 1071–119. Scopus, doi:10.1007/978-3-030-36438-0_32.
Pina-Oviedo S. Malignant Hematopoietic Disorders of the Mediastinum. Diagnostic Thoracic Pathology. 2020. p. 1071–1119.

DOI

Publication Date

January 1, 2020

Start / End Page

1071 / 1119